Shares of ADC Therapeutics SA (NYSE:ADCT – Get Free Report) have been given a consensus rating of “Hold” by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy […]
ADC Therapeutics SA (NYSE:ADCT – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The […]
The stock of Adc Therapeutics SA (NYSE: ADCT) has increased by 3.40 when compared to last closing price of 0.81.Despite this, the company has seen a loss of -2.62% in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-05 that LAUSANNE, Switzerland, Sept. 05, 2023 (GLOBE
Adc Therapeutics SA (NYSE: ADCT)’s stock price has gone rise by 12.31 in comparison to its previous close of 0.72, however, the company has experienced a 4.26% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-05 that LAUSANNE, Switzerland, Sept. 05, 2
ADC Therapeutics SA (NYSE:ADCT – Free Report) – Investment analysts at HC Wainwright lifted their Q3 2023 earnings estimates for shares of ADC Therapeutics in a research note issued on Tuesday, September 19th. HC Wainwright analyst R. Burns now forecasts that the company will earn ($0.67) per share for the quarter, up from their previous […]